Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 June 2025 | Story Tshepo Tsotetsi | Photo Tshepo Tsotetsi
Broadening Curricula Debate
Debaters from the Faculty of Economic and Management Sciences’ 2025 Broadening Curricula Debate.

In an engaging and thought-provoking session, the Faculty of Economic and Management Sciences (EMS) at the University of the Free State hosted its Broadening Curricula Faculty Debate Series under the motion: The current Economic and Management Sciences curricula, pedagogical approaches, and research endeavours perpetuate colonial legacies. Held on the Bloemfontein Campus on 3 June 2025, the debate brought together academics and, for the first time, students – making space for dynamic, intergenerational dialogue on the transformation of teaching and learning in higher education.

 

Creating space for critical pedagogical reflection

Annari Muller, manager of Teaching and Learning Manager in the faculty, said the aim was to provide a platform for constructive, sometimes challenging, engagement. “We create a platform for staff to debate these things and ultimately inform our practice, policy, pedagogy, and what we teach and how we teach,” she said.

For the first time, students were formally included in the debating teams, following feedback from previous events. “It is very important to include student perspectives as well,” Muller noted. “We want to continue these discussions, take them forward into our research practices and learning and teaching committees, where we will dissect them and act on the next step.”

This inclusion added new layers to the debate. Elda Nhalunga responsible for master’s student administration, said the topic immediately resonated with her. “When I saw decolonisation and curriculum in one motion, I found it very interesting and decided that this was something I wanted to be part of. I also wanted to hear what other scholars were saying.” She added: “Through these small initiatives, we are working towards transformation. And it’s important that students be there so that their voices are heard.”

 

Towards a more inclusive and just Academic Project

Prof Frans Prinsloo, Vice-Dean for Learning and Teaching, Innovation and Digitalisation,  believes that debates of this nature play a vital role in shaping inclusive academic spaces. “Debates, such as the one on decolonisation, enable us to engage with and reflect deeply on complex issues and to challenge existing assumptions. Through this process, the faculty can enhance its teaching practices and curriculum development.”

According to Prof Prinsloo, this kind of engagement is just the beginning. “The debate is but the start of the faculty’s plan to ensure that its Academic Project is decolonised. Research is currently in process to gather perceptions of staff and students on the topic. This research will drive action.”

Lukhanyo Lekeno, Economics master’s student, echoed this sentiment, calling the topic timely and essential. “We’re living in a world where there are certain standards and norms that, in most cases, exclude and marginalise people,” he said. “When we start having conversations about decoloniality, we are taking a step closer to actually dismantling certain legacies and ideologies that keep people constrained within a mindset.” Lekeno encouraged others to engage in such conversations, describing it as an ‘exchange of knowledge, systems, and perspectives’, which contributes to both personal growth and academic transformation.

Previous sessions in the series, such as the 2024 debate on socio-environmental sustainability, have prompted internal curriculum reviews, underscoring the faculty’s intention to link dialogue with institutional reflection.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept